08:30         Registration, Partnering Meetings & Networking in the Exhibition Hall

09:00         Welcome & Introduction
                       Pernille Hemmingsen, Chief Technology Officer, Adcendo         

09:05         The Pharma Industry in Challenging Times       
                       Sara Lowemark, Director International Affairs, Lif 

09:25         AI- and Data-Driven Discovery: Accelerating Drug Development and Reducing Risk
                       Danuta Gawel, Chief Research and Development Officer, Mavatar

09:45         Next Generation Brain Therapies – Unlocking the Potential for Treatments That Were Once Out of Reach
                       Elisabet Sjöström, CEO & Founder, Key2brain

10:05         Coffee, Partnering Meetings & Networking in the Exhibition hall

10:45         From Concept to Candidate: Innovative Technologies in Early Drug Discovery
                       Nuska Tschammer, Senior Director, In Vitro Discovery Biology, WuXi AppTec

11:05         No More Subjectivity: High-Sensitivity, Quantitative Tissue Biomarker Analysis for Confident Drug Development
                       Sanna Wallenborg, CEO, Lumito

11:25         Solving Bioavailability – Realizing the Full Potential of Oral Drugs with Formulite™
                       Peter Åsberg, CEO, Disruptive Pharma

11:45         Lunch, Partnering Meetings & Networking in the Exhibition

12:45         Stories From Inside
                       Kristofer Klerfalk, CEO & Co-founder, Life Science Invest

13:05         Raising Capital in Life Science: Challenges, Insights, and Opportunities
                       Okee Williams, Corporate Advisory, RedEye

13:25         Coffee, Partnering Meetings & Networking in the Exhibition Hall

14:10         Beyond Incretins: How Atrogi is Reshaping the Fight Against Obesity and Diabetes
                       Tore Bengtsson, Founder & CSO, Atrogi

14:30          Is It Really Nice to Be in the Middle of the Obesity Hype?
                        Arvid Söderhäll, CEO, Empros Pharma

14:50          From Concept to Clinic: Leveraging Outsourcing to Accelerate Innovation in Rare Cardiovascular and Pulmonary Diseases
                        Rahul Agrawal, Chief Medical Officer & Head of R&D, Cereno Scientific

15:10          Navigating the Early Clinical Path: From Preclinical Development to FIH and PoC
                        Sandra Kuusk, Chief Scientific Officer
                        Johan Bylund, Director DMPK and Clinical Pharmacology
                        CTC Clinical Trial Consultants

15:30          Summary & Conclusion
                        Pernille Hemmingsen, Chief Technology Officer, Adcendo

15:30-17:30   Life Science Sweden’s Annual Christmas Reception – Included for All Attendees

                        Continue your networking in a festive atmosphere while enjoying traditional Swedish Christmas refreshments, accompanied by a selection of beverages (non-alcoholic options are available, too).
                        
                        The reception also includes an inspiring talk (approx. 16:00) by Nuska Tschammer, Senior Director, In Vitro Discovery Biology, WuXi AppTec:
                        Precision, Partnership, Possibility: Shaping Early Drug Discovery Together.